Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Parathyroid Allotransplant for Treatment of Hypoparathyroidism: PATTH

NCT06961071 is registered in ClinicalTrials.gov with Peter Stock as lead sponsor.

NCT NCT06961071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06961071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Parathyroid Allotransplant for Treatment of Hypoparathyroidism: PATTH
Lead sponsor
Peter Stock
Phase
Phase 1/2
Overall status
Recruiting
Start date
January 15, 2026
Completion date
January 15, 2028
Enrollment
3 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoparathyroidism, hypoparathyroidism post-surgical, hypoparathyroidism postprocedural